Skip to content

Validation of the Polish Version of the MPIIQM Questionnaire for Musicians

Validation of the Polish Version of the Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians (MPIIQM-P)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05903300
Enrollment
182
Registered
2023-06-15
Start date
2023-04-17
Completion date
2023-12-01
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Pain, Questionnaire

Keywords

Occupational Diseases, Musculoskeletal Pain, Questionnaires, Validation Studies, Pain Measurement

Brief summary

The aim of this study, originally named Cross-Cultural Adaptation and Validation of the Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians of the Polish Population (MPIIQM-P) is the enlargement of validation of the Polish questionnaire.

Detailed description

The aim is to determine the following psychometric properties: convergent and divergent validity, two-time reliability analysis, and exploratory factor analysis according to the recommended number of subjects of ≥45 subjects. In addition, the aim of the study is to assess the psychometric properties of the MPIIQM-P questionnaire in the online version and to compare these results with the results for the paper version obtained by Cygańska et al., 2021.

Interventions

OTHERSurveys and Questionnaires

The intervention consists of completing the MIPIM-P, QuickDash, and Brief Pain Inventory questionnaires.

Sponsors

Anna Cygańska
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* permanent musician in an orchestra * Polish as a native language

Exclusion criteria

• freelance musician

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity MPIQIMBaseline and change between baseline and after few (3/4) daysThe Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); The pain intensity score can be defined as the sum of the four pain intensity items (0-40, the higher the score, the greater the pain intensity) or the mean of pain intensity score (0-10, the higher the score, the greater the pain intensity).
Pain Intensity BPIBaseline and change between baseline and after few (3/4) daysIn Brief Pain Inventory, subjects rates their pain intensity on a numeric rating scale from 0 to 10, the higher the score, the greater the pain intensity. The pain intensity score can be defined as the sum of the four pain intensity items (0-40, the higher the score, the greater the pain intensity). In the inventory, a score of 1-4 is defined as mild pain, a score of 5-6 as moderate pain, and a score of 7-10 as severe pain.
Pain Interference MPIQIMBaselineThe Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); The pain interference score can be defined as the sum of the four pain interference items (0-50, the higher the score, the greater the pain interference) or the mean of pain interference score (0-10, the higher the score, the greater the pain interference).
Pain Interference BPIBaselineIn Brief Pain Inventory, subjects rate their pain interference on a numeric rating scale from 0 to 10, the higher the score, the greater the pain interference. The pain interference score can be defined as the sum of the four pain interference items (0-70, the higher the score, the greater the pain intensity) or the mean of the pain interference score (0-10, the higher the score, the greater the pain interference).
Pain InterferenceBaselineIn Quick Dash Questionaire, subjects rate their pain interference on a numeric rating scale from 0 to 5, the higher the score, the greater the pain interference. The pain interference score can be defined as the sum of the selected answers, divided by 4 (i.e. number of questions), subtracting 1, and multiply by 25.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026